INS and Alzheimer disease: It has been observed that the decreased activity, low concentrations, and small amounts of mRNA of insulin‐degrading enzyme in brains of patients with AD and knockout mice that lack the enzyme have reduced degradation of Aβ and insulin in brain (Lam & Lu, 2007; Li et al., 2002; Shanley, Irving, & Harvey, 2001).